VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $581,000 | -12.6% | 25,000 | -40.1% | 0.28% | +80.3% |
| Q1 2018 | $665,000 | -4.5% | 41,750 | +24.6% | 0.16% | -0.6% |
| Q4 2017 | $696,000 | -59.8% | 33,500 | -66.5% | 0.16% | -70.5% |
| Q2 2017 | $1,730,000 | +526.8% | 100,000 | +300.0% | 0.54% | +654.9% |
| Q1 2017 | $276,000 | -95.5% | 25,000 | -94.1% | 0.07% | -97.5% |
| Q4 2016 | $6,171,000 | +1431.3% | 425,000 | +2025.0% | 2.88% | +1467.4% |
| Q2 2016 | $403,000 | -52.1% | 20,000 | -37.5% | 0.18% | -4.2% |
| Q1 2016 | $842,000 | -83.4% | 32,000 | -36.0% | 0.19% | -88.2% |
| Q4 2015 | $5,083,000 | +2035.7% | 50,000 | +4559.8% | 1.63% | +3975.0% |
| Q2 2015 | $238,000 | – | 1,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |